Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7251 results

Sort By:

Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer

Study ID: NCT05535894
Start Date: 2022-08-10
End Date: 2025-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

Ablation of Celiac Ganglion

Sponsor

West Virginia University

Source: clinicaltrials.gov

Share:
Add to list

Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

Study ID: NCT04068194
Start Date: 2020-04-07
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

103

Intervention / Treatment

Avelumab

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Hypofractionated Radiation Therapy

Peposertib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Safety of Phentermine/Topiramate in Youth with Hypothalamic Obesity

Study ID: NCT06299891
Start Date: 2025-03-01
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

24

Intervention / Treatment

Phentermine / Topiramate Extended Release Oral Capsule [Qsymia]

Placebo

Sponsor

Seattle Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Study ID: NCT03871257
Start Date: 2020-01-15
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

165

Intervention / Treatment

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Administration questionnaire

Selumetinib Sulfate

Vincristine Sulfate

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis

Study ID: NCT05950282
Start Date: 2024-02-01
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment
Sponsor

Lilli Health

Source: clinicaltrials.gov

Share:
Add to list

Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Study ID: NCT03547973
Start Date: 2018-08-13
End Date: 2030-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

827

Intervention / Treatment

Sacituzumab Govitatan-Kzius

Pembrolizumab

Cisplatin

Avelumab

Zimberelimab

Carboplatin

Gemcitabine

Domvanalimab

Emportumab Vedotin

Sponsor

Gilead Sciences

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer

Study ID: NCT06318273
Start Date: 2024-03-08
End Date: 2027-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

140

Intervention / Treatment

Abbv-969

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

The INSPIRE-Lung Study

Study ID: NCT05824273
Start Date: 2023-08-02
End Date: 2027-07-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

500

Intervention / Treatment

Lungtalk

Non-tailored intervention - Standard of practice

Sponsor

Hackensack Meridian Health

Source: clinicaltrials.gov

Share:
Add to list

67Cu-SARTATE™ Peptide Receptor Radionuclide Therapy Administered to Pediatric Patients With High-Risk, Relapsed, Refractory Neuroblastoma

Study ID: NCT04023331
Start Date: 2020-08-18
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

67Cu-SARTATE

64CU-SARTED

Sponsor

Clarity Pharmaceuticals Ltd

Source: clinicaltrials.gov

Share:
Add to list

Prospective Evaluation of Targeted Axillary Dissection (TAD)

Study ID: NCT04998682
Start Date: 2022-03-01
End Date: 2026-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment

Axillary Dissection

Sponsor

University of Miami

Source: clinicaltrials.gov

Share:
Add to list